Prospective Multicenter Validation of Androgen Receptor Splice Variant 7 and Hormone Therapy Resistance in High-Risk Castration-Resistant Prostate Cancer: The PROPHECY StudyAndrew J. Armstrong, Daniel J. George, Daniel C. Danila et al.|Journal of Clinical Oncology|2019Cited by 364
Interim results of an ongoing Phase I, dose escalation study of MGA271 (Fc-optimized humanized anti-B7-H3 monoclonal antibody) in patients with refractory B7-H3-expressing neoplasms or neoplasms whose vasculature expresses B7-H3John D. Powderly, Bartosz Chmielowski, Gregory M. Coté et al.|Journal for ImmunoTherapy of Cancer|2015Cited by 101
SOX2 expression in prostate cancer drives resistance to nuclear hormone receptor signaling inhibition through the WEE1/CDK1 signaling axisAnthony Williams, Russell Z. Szmulewitz|Cancer Letters|2023Cited by 16